SB
Samsara BioCapital Portfolio holdings
AUM
$489M
1-Year Est. Return
135.25%
1 Year Est. Return
+135.25%
AUM
$489M
AUM Growth
-$71.9M
(-13%)
Holding
39
Top Sells
1 | +$7.66M | |
2 | +$6.85M | |
3 | +$6.23M | |
4 |
Rhythm Pharmaceuticals
RYTM
|
+$5.54M |
5 |
LENZ
LENZ Therapeutics
LENZ
|
+$5.37M |
Sector Composition
1 | Healthcare | 99.99% |
New
Increased
Maintained
Reduced
Closed
Stocks
ETFs
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
# | Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
---|---|---|---|---|---|---|---|
1 |
1
Scholar Rock
SRRK
$2.69B
| $199M | 40.66% |
5,612,896
|
|
||
2 |
2
Mineralys Therapeutics
MLYS
$3.38B
| $76.8M | 15.7% |
5,674,916
|
|
||
3 |
SEPN
3
Septerna Inc
SEPN
$984M
| $33.3M | 6.81% |
3,149,128
|
|
||
4 |
KLRS
4
Kalaris Therapeutics
KLRS
$86.6M
| $30.6M | 6.25% |
11,448,081
|
|
||
5 |
5
Neurogene
NGNE
$414M
| $25.7M | 5.25% |
1,717,127
|
|
||
6 |
CRGX
6
DELISTED
CARGO Therapeutics
CRGX
| $18.2M | 3.72% |
4,415,689
|
|
||
7 |
UPB
7
Upstream Bio Inc
UPB
$1.13B
| $15.8M | 3.24% |
1,443,231
-623,915
|
|
||
8 |
ALMS
8
Alumis Inc
ALMS
$467M
| $14.4M | 2.95% |
4,801,370
+1,534,872
|
|
||
9 |
LENZ
9
LENZ Therapeutics
LENZ
$1.16B
| $10.1M | 2.06% |
343,012
-183,378
|
|
||
10 |
PVLA
10
Palvella Therapeutics
PVLA
$809M
| $7.66M | 1.57% |
339,743
-339,743
|
|
||
11 |
11
Gossamer Bio
GOSS
$501M
| $7.54M | 1.54% |
6,130,268
|
|
||
12 |
12
Arcellx
ACLX
$4.82B
| $6.68M | 1.37% |
101,457
-33,819
|
|
||
13 |
13
Aura Biosciences
AURA
$352M
| $6.26M | 1.28% |
+1,000,000
|
|
||
14 |
14
Nkarta
NKTX
$163M
| $6.25M | 1.28% |
3,768,035
|
|
||
15 |
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.48B
| $5.98M | 1.22% |
675,504
-292,023
|
|
||
16 |
JBIO
16
Jade Biosciences
JBIO
$431M
| $5.31M | 1.09% |
+531,163
|
|
||
17 |
17
Zymeworks
ZYME
$1.39B
| $3.89M | 0.8% |
310,300
-356,367
|
|
||
18 |
18
Rhythm Pharmaceuticals
RYTM
$7.32B
| $3.19M | 0.65% |
50,476
-87,642
|
|
||
19 |
19
vTv Therapeutics
VTVT
$52.9M
| $3.1M | 0.63% |
206,784
|
|
||
20 |
CTNM
20
Contineum Therapeutics
CTNM
$328M
| $2.34M | 0.48% |
588,816
|
|
||
21 |
21
Surrozen
SRZN
$116M
| $2.16M | 0.44% |
241,400
|
|
||
22 |
22
Sutro Biopharma
STRO
$85.6M
| $1.57M | 0.32% |
2,196,814
|
|
||
23 |
23
Tango Therapeutics
TNGX
$1B
| $1.08M | 0.22% |
210,000
-420,000
|
|
||
24 |
HLVX
24
DELISTED
HilleVax
HLVX
| $795K | 0.16% |
399,637
|
|
||
25 |
25
Terns Pharmaceuticals
TERN
$736M
| $755K | 0.15% |
202,348
|
|